Table of Content



1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets

4. Market Characterisitics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Segmentation
4.6. Market Dynamics
4.6.1. Drivers
4.6.2. Restraints
4.6.3. Opportunities
4.7. DRO - Impact Analysis

5. Animal Type: Market Size & Analysis
5.1. Overview
5.2. Poultry
5.3. Swine,
5.4. Livestock
5.5. Aquatic animals
5.6. Other animals

6. Type of Drug: Market Size & Analysis
6.1. Overview
6.2. Antibiotic Growth Promoters
6.3. Non-Antibiotics
6.3.1. Prebiotics & Probiotics

6.3.2. Phytogenics
6.3.3. Feed Enzymes
6.3.4. Hormones

7. Geography: Market Size & Analysis
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia Pacific
7.5. Rest of the World

8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.3. Mergers and Acquisitions, Legal, Awards, Partnerships
8.4. Product Launches and execution

9. Vendor Profiles
9.1. Elanco Animal Health Inc
9.1.1. Overview
9.1.2. Product Offerings
9.1.3. Geographic Revenue
9.1.4. Business Units
9.1.5. Developments
9.1.6. SWOT Analysis
9.1.7. Business Strategy
9.2. Royal DSM N.V
9.2.1. Overview
9.2.2. Product Offerings
9.2.3. Geographic Revenue
9.2.4. Business Units
9.2.5. Developments
9.2.6. SWOT Analysis
9.2.7. Business Strategy
9.3. Cargill, Inc
9.3.1. Overview
9.3.2. Product Offerings
9.3.3. Geographic Revenue
9.3.4. Business Units
9.3.5. Developments

9.3.6. SWOT Analysis
9.3.7. Business Strategy
9.4. Merck & Co., Inc
9.4.1. Overview
9.4.2. Product Offerings
9.4.3. Geographic Revenue
9.4.4. Business Units
9.4.5. Developments
9.4.6. SWOT Analysis
9.4.7. Business Strategy
9.5. Alltech, Inc
9.5.1. Overview
9.5.2. Product Offerings
9.5.3. Geographic Revenue
9.5.4. Business Units
9.5.5. Developments
9.5.6. SWOT Analysis
9.5.7. Business Strategy
9.6. Vetoquinol
9.6.1. Overview
9.6.2. Product Offerings
9.6.3. Geographic Revenue
9.6.4. Business Units
9.6.5. Developments
9.6.6. SWOT Analysis
9.6.7. Business Strategy
9.7. Bupo Animal Health
9.7.1. Overview
9.7.2. Product Offerings
9.7.3. Geographic Revenue
9.7.4. Business Units
9.7.5. Developments
9.7.6. SWOT Analysis
9.7.7. Business Strategy
9.8. Archer-Daniels-Midland Company
9.8.1. Overview
9.8.2. Product Offerings

9.8.3. Geographic Revenue
9.8.4. Business Units
9.8.5. Developments
9.8.6. SWOT Analysis
9.8.7. Business Strategy
9.9. Chr. Hansen
9.9.1. Overview
9.9.2. Product Offerings
9.9.3. Geographic Revenue
9.9.4. Business Units
9.9.5. Developments
9.9.6. SWOT Analysis
9.9.7. Business Strategy
9.10. Novus International, Inc
9.10.1. Overview
9.10.2. Product Offerings
9.10.3. Geographic Revenue
9.10.4. Business Units
9.10.5. Developments
9.10.6. SWOT Analysis
9.10.7. Business Strategy


10. Companies to Watch
10.1. Erber AG
10.1.1. Overview
10.1.2. Market
10.1.3. Business Strategy
10.2. Kemin Industries
10.2.1. Overview
10.2.2. Market
10.2.3. Business Strategy
10.3. Associated British Foods PLC
10.3.1. Overview
10.3.2. Market
10.3.3. Business Strategy
10.4. Nutreco, Erber AG
10.4.1. Overview

10.4.2. Market
10.4.3. Business Strategy
10.5. BASF SE
10.5.1. Overview
10.5.2. Market
10.5.3. Business Strategy
10.6. Phibro Animal Health Corporation
10.6.1. Overview
10.6.2. Market
10.6.3. Business Strategy
10.7. Evonik Industries AG
10.7.1. Overview
10.7.2. Market
10.7.3. Business Strategy
10.8. Bluestar Adisseo Company
10.8.1. Overview
10.8.2. Market
10.8.3. Business Strategy
10.9. Land O’lakes, Inc
10.9.1. Overview
10.9.2. Market
10.9.3. Business Strategy
10.10. Lallemand Inc.
10.10.1. Overview
10.10.2. Market
10.10.3. Business Strategy


11. Analyst Opinion

12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions

12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations



List of Figures


CHART. 1. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE
BY ANIMAL TYPE, 2020-2026 (USD BILLION)

CHART. 2. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 3. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 4. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 5. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 6. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 7. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE
BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

CHART. 8. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 9. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 10. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS

MARKET VALUE, BY ANIMAL TYPE, 2020-2026 (USD BILLION)

CHART. 11. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS

MARKET VALUE FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 12. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS

MARKET VALUE FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 13. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS

MARKET VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 14. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS

MARKET VALUE, BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

CHART. 17. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS

MARKET VALUE FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 18. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
MARKET VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE
BY ANIMAL TYPE, 2020-2026 (USD BILLION)

CHART. 20. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 21. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 22. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 23. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 24. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 25. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE
BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

CHART. 26. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 27. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 28. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY ANIMAL TYPE, 2020-2026 (USD BILLION)

CHART. 29. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 30. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 31. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 32. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 33. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 34. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

CHART. 35. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 36. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 37. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY ANIMAL TYPE, 2020-2026 (USD BILLION)

CHART. 38. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 39. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 40. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 41. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 42. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 43. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

CHART. 44. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 45. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

CHART. 46. ELANCO ANIMAL HEALTH INC.: SWOT ANALYSIS
CHART. 47. ROYAL DSM N.V: SWOT ANALYSIS
CHART. 48. CARGILL, INC: SWOT ANALYSIS
CHART. 49. MERCK & CO., INC: SWOT ANALYSIS
CHART. 50. ALLTECH, INC: SWOT ANALYSIS
CHART. 51. VETOQUINOL: SWOT ANALYSIS
CHART. 52. BUPO ANIMAL HEALTH: SWOT ANALYSIS
CHART. 53. ARCHER-DANIELS-MIDLAND COMPANY: SWOT ANALYSIS
CHART. 54. CHR. HANSEN: SWOT ANALYSIS
CHART. 55. NOVUS INTERNATIONAL, INC: SWOT ANALYSIS


List of Tables



TABLE 1. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY

ANIMAL TYPE, 2020-2026 (USD BILLION)

TABLE 2. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY

TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 10. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY ANIMAL TYPE, 2020-2026 (USD BILLION)

TABLE 11. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 12. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 13. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 14. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 15. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 16. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

TABLE 17. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 18. NORTH AMERICA ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 19. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY

ANIMAL TYPE, 2020-2026 (USD BILLION)

TABLE 20. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 21. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 22. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 23. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 24. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 25. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE, BY

TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

TABLE 26. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 27. EUROPE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET VALUE

FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 28. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY ANIMAL TYPE, 2020-2026 (USD BILLION)

TABLE 29. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 30. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 31. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 32. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 33. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 34. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

TABLE 35. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 36. ASIA PACIFIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 37. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY ANIMAL TYPE, 2020-2026 (USD BILLION)

TABLE 38. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR POULTRY, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 39. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR SWINE, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 40. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR LIVESTOCK, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 41. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR AQUATIC ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 42. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR OTHER ANIMALS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 43. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE, BY TYPE OF DRUG/CHEMICAL, 2020-2026 (USD BILLION)

TABLE 44. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 45. REST OF WORLD ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

VALUE FOR NON-ANTIBIOTICS, BY GEOGRAPHY, 2020-2026 (USD BILLION)

TABLE 46. Elanco Animal Health Inc.: OVERVIEW
TABLE 47. Elanco Animal Health Inc.: STRATEGIC SNAPSHOT
TABLE 48. Elanco Animal Health Inc.: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 49. Elanco Animal Health Inc.: PRODUCT/SERVICE PORTFOLIO
TABLE 50. ROYAL DSM N.V: OVERVIEW
TABLE 51. ROYAL DSM N.V: STRATEGIC SNAPSHOT
TABLE 52. ROYAL DSM N.V: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 53. ROYAL DSM N.V: PRODUCT/SERVICE PORTFOLIO
TABLE 54. CARGILL, INC: OVERVIEW
TABLE 55. CARGILL, INC: STRATEGIC SNAPSHOT
TABLE 56. CARGILL, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 57. CARGILL, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 58. MERCK & CO., INC: OVERVIEW
TABLE 59. MERCK & CO., INC: STRATEGIC SNAPSHOT
TABLE 60. MERCK & CO., INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 61. MERCK & CO., INC: PRODUCT/SERVICE PORTFOLIO
TABLE 62. ALLTECH, INC: OVERVIEW
TABLE 63. ALLTECH, INC: STRATEGIC SNAPSHOT
TABLE 64. ALLTECH, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 65. ALLTECH, INC: PRODUCT/SERVICE PORTFOLIO
TABLE 66. VETOQUINOL: OVERVIEW
TABLE 67. VETOQUINOL: STRATEGIC SNAPSHOT
TABLE 68. VETOQUINOL: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 69. VETOQUINOL: PRODUCT/SERVICE PORTFOLIO
TABLE 70. BUPO ANIMAL HEALTH: OVERVIEW
TABLE 71. BUPO ANIMAL HEALTH: STRATEGIC SNAPSHOT
TABLE 72. BUPO ANIMAL HEALTH: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 73. BUPO ANIMAL HEALTH: PRODUCT/SERVICE PORTFOLIO
TABLE 74. ARCHER-DANIELS-MIDLAND COMPANY: OVERVIEW
TABLE 75. ARCHER-DANIELS-MIDLAND COMPANY: STRATEGIC SNAPSHOT
TABLE 76. ARCHER-DANIELS-MIDLAND COMPANY: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 77. ARCHER-DANIELS-MIDLAND COMPANY: PRODUCT/SERVICE PORTFOLIO

TABLE 78. CHR. HANSEN: OVERVIEW
TABLE 79. CHR. HANSEN: STRATEGIC SNAPSHOT
TABLE 80. CHR. HANSEN: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 81. CHR. HANSEN: PRODUCT/SERVICE PORTFOLIO
TABLE 82. NOVUS INTERNATIONAL, INC: OVERVIEW
TABLE 83. NOVUS INTERNATIONAL, INC: STRATEGIC SNAPSHOT
TABLE 84. NOVUS INTERNATIONAL, INC: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 85. NOVUS INTERNATIONAL, INC: PRODUCT/SERVICE PORTFOLIO